Pooled analysis of phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin
By February 2026, eight GLP-1 RAs have received FDA approval, primarily for glycemic control in T2D and chronic weight management in obesity, with expanding cardiovascular (CV) benefits demonstrated in large-scale trials
However, as with any effective treatment, your body must adjust to these changes
It took insurance companies years to begin covering bariatric surgery, and now there's a reluctance to cover drugs prescribed for weight loss
2021 Jul 10;398(10295):143-155
In this last part of our Retinoid Ingredient Series, we provide a step-by-step guide to using Retinoids in your daily routine and talk about some effective combinations when layering